Comments on: Click Therapeutics and Boehringer Ingelheim Announce FDA Breakthrough Device Designation for Prescription Digital Therapeutic to Treat Negative Symptoms of Schizophrenia
https://www.digitalhealthglobal.com/click-therapeutics-and-boehringer-ingelheim-announce-fda-breakthrough-device-designation-for-prescription-digital-therapeutic-to-treat-negative-symptoms-of-schizophrenia/
digital health tools and servicesTue, 27 Feb 2024 10:22:28 +0000
hourly
1 https://wordpress.org/?v=5.8